Multiple Myeloma /

Round 1: What is the Optimal Partner for CD38 Therapy in First Relapse_Jonathan Kaufman, MD and Saad Usmani, MD, MBA, FACP

29:23

Multiple Myeloma

Multiple Myeloma Similar Videos

Similar Videos

Module 4_BCMA-Targeted Bispecifics

22:12
Virtual Challenging Case Clinic: Multiple Myleloma_Management of Early Relapse in the Evolving Treatment World_Krina Patel, MD, MSc

53:28
Module 3_BCMA-Targeted Antibody-Drug Conjugates (ADCs)

9:40

ABOUT

Bio Ascend is an independent medical education company committed to supporting healthcare providers in their efforts to translate innovative science into clinical practice.

The Bio Ascend team has deep oncology and hematology expertise with a proven ability to distill complex scientific ideas into their essential components, as well as extensive experience in planning, executing, and assessing meaningful education for clinicians.

CONNECT

support@bioascend.com

(888) 476-9129

980 North Michigan Avenue, Suite 1400, Chicago, IL 60611